Gut microbiome and immunotherapy response

Taxonomic profiling of available faecal microbiome samples (n=43) showed significant differences between patients who responded to therapy (n=30) and those who did not (n=13; p

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2017-12, Vol.18 (12), p.e717-e717
1. Verfasser:	Burki, Talha Khan
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteria Disease-Free Survival Faecalibacterium Female Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - immunology Humans Immunotherapy Immunotherapy - methods Intestinal microflora Male Melanoma Melanoma - immunology Melanoma - mortality Melanoma - pathology Melanoma - therapy Mouth Mucosa - drug effects Mouth Mucosa - immunology Neoplasm Invasiveness - pathology Neoplasm Staging Predictive Value of Tests Programmed Cell Death 1 Receptor - antagonists & inhibitors Proportional Hazards Models Risk Assessment Skin Neoplasms - immunology Skin Neoplasms - mortality Skin Neoplasms - pathology Skin Neoplasms - therapy Survival Analysis Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Taxonomic profiling of available faecal microbiome samples (n=43) showed significant differences between patients who responded to therapy (n=30) and those who did not (n=13; p
ISSN:	1470-2045 1474-5488
DOI:	10.1016/S1470-2045(17)30841-0